Literature DB >> 1941813

Phenotypic characteristics of T cells interacted with synovial cells.

N Matsuoka1, K Eguchi, A Kawakami, H Ida, M Nakashima, M Sakai, K Terada, S Inoue, Y Kawabe, A Kurata.   

Abstract

We demonstrated the phenotypic characteristics of T cells interacted with synovial fibroblast-like cells. A small percentage of peripheral blood T cells adhered to synovial fibroblast-like cells. When synovial cells were treated with interferon-gamma or interleukin-1 beta, the percentage of T cells that adhered to the treated cells markedly increased in comparison with the value for untreated synovial cells. The kinesis of T cell adherence to treated synovial cells differed from that of HLA-DR antigen expression on synovial cells. T cell adherence was not blocked by mouse monoclonal anti-HLA-DR and anti-HLA-ABC antibodies. The phenotypes of the adherent and nonadherent T cells were investigated with a flow cytometer. The CD29 + subset was more adhesive than the CD45RA + subset to IL-1 beta-stimulated synovial cells. The proportions of high density lymphocyte function associated antigen (LFA)-1 alpha and LFA-1 beta were greater in the adherent than in the nonadherent T cells, and the mean fluorescence intensities of LFA-1 alpha, LFA-1 beta and CD2 molecules on adherent T cells were significantly higher than those on nonadherent T cells. Our results support the concept that an interaction between infiltrating lymphocytes and synovial cells occurs in the synovium, resulting in the initiation and perpetuation of immune responses in synovial tissue in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941813

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis.

Authors:  A Kawakami; K Eguchi; N Matsuoka; M Tsuboi; S Urayama; Y Kawabe; T Aoyagi; K Maeda; S Nagataki
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.

Authors:  Chinh N Tran; Steven K Lundy; Peter T White; Judith L Endres; Christopher D Motyl; Raj Gupta; Cailin M Wilke; Eric A Shelden; Kevin C Chung; Andrew G Urquhart; David A Fox
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

3.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

4.  CD4+ T-cell-mediated cytotoxicity against staphylococcal enterotoxin B-pulsed synovial cells.

Authors:  A Kawakami; N Matsuoka; M Tsuboi; S Urayama; T Nakashima; Y Kawabe; T Koji; T Aoyagi; K Maeda; K Eguchi
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

5.  Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts.

Authors:  J F Schlaak; A Schwarting; P Knolle; K H Meyer zum Büschenfelde; W Mayet
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

6.  Synovial cells are potent antigen-presenting cells for superantigen, staphylococcal enterotoxin B (SEB).

Authors:  T Origuchi; K Eguchi; Y Kawabe; A Mizokami; H Ida; S Nagataki
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

7.  Increment of CD8S6F1 cells in synovial fluid from patients with rheumatoid arthritis.

Authors:  Y Ueki; K Eguchi; S Miyake; S Nagataki; Y Tominaga
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

8.  Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding.

Authors:  H Shimada; K Eguchi; Y Ueki; M Nakashima; I Yamashita; Y Kawabe; M Sakai; H Ida; T Aoyagi; S Nagataki
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.